Scientech Research’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
Scientech Research's CORT Position: Q1 2026 in Review
Scientech Research sold out of Corcept Therapeutics (CORT) in Q1 2026, closing a stake of 13,915 shares — an estimated $484K sold.
Scientech Research first reported a position in CORT in Q4 2024 and held it in 3 quarters. The position peaked at $1.62M in Q1 2025. 353 funds tracked by Wall St. Rank hold CORT as of Q1 2026.
- Scientech Research reported no remaining Corcept Therapeutics position as of Q1 2026 after selling out during the quarter.
- Scientech Research sold 13,915 Corcept Therapeutics shares in Q1 2026, an estimated $484K.
- Scientech Research first reported a position in Corcept Therapeutics in Q4 2024 and held it in 3 quarters.
- Scientech Research's Corcept Therapeutics position peaked at $1.62M in Q1 2025.
- 353 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.
Based on Scientech Research's 13F filing for Q1 2026, filed 15 May 2026.